POC Performance Evaluation of LumiraDx SARS-CoV-2 Ag Ultra and SARS-CoV-2 & Flu A/B Tests.

Clinical trial NCT05728970 · COMPLETED

Trial details

NCT number: NCT05728970
Sponsor: LumiraDx UK Limited
Status: COMPLETED
Study type: OBSERVATIONAL

SARS-CoV-2 Influenza A Influenza B COVID-19

Start date: 2023-02-09
Primary completion: 2023-04-11
Enrollment: 716

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.